Contact Information: Contact: Zackary Irani 949-645-2111
IRVINE, CA--(Marketwire - October 28, 2009) - Biomerica, Inc. (OTCBB : BMRA ), a global provider
of advanced diagnostic products for the early detection of medical
conditions, today announced their move to a new Corporate, R&D and
Manufacturing facility in Irvine, California.
Biomerica's new state of the art facility is the result of a two-year
search of possible buildings in the Orange County area. This new facility
will afford efficiency, production, and quality assurance improvements. The
manufacturing layouts have taken job and process flow into account. The
warehouse and refrigeration areas have been appropriately located for
optimal work flow. In this new facility, Biomerica will now have the
opportunity to continue its growth as a global provider of diagnostic
products. The Company expects to complete its move by mid-November 2009.
Irvine is one of the nation's largest planned urban communities and
encompasses more than 65 square miles. The new Biomerica building is less
than 2 miles from John Wayne Orange County Airport and within 4 miles of
the University of California Irvine, a leading medical school.
The company's new address is: Biomerica, Inc., 17571 Von Karman Ave,
Irvine CA 92614. The Company's phone number remains the same
(949-645-2111).
About Biomerica (OTCBB : BMRA )
Biomerica, Inc. (www.biomerica.com) is a global medical technology company,
based in Irvine, CA. The Company manufactures and markets advanced
diagnostic products used at home, in hospitals, and in physicians' offices
for the early detection of medical conditions and diseases.
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Certain information included in
this press release (as well as information included in oral statements or
other written statements made or to be made by Biomerica) contains
statements that are forward-looking; such as statements relating to
intended launch dates, expected improvements in performance, expected
product introductions, sales potential, market size, growth of business,
favorable positions, efficiencies, work flow, leading market positions,
success of product and new product offerings. Such forward-looking
information involves important risks and uncertainties that could
significantly affect anticipated results in the future, and accordingly,
such results may differ materially from those expressed in any
forward-looking statements made by or on behalf of Biomerica. The potential
risks and uncertainties include, among others, fluctuations in the
Company's operating results due to its business model and expansion plans,
downturns in international and or national economies, the Company's ability
to raise additional capital, the competitive environment in which the
Company will be competing, and the Company's dependence on strategic
relationships. The Company is under no obligation to update any
forward-looking statements after the date of this release.
